{"id":"https://openalex.org/W100713916","doi":"https://doi.org/10.1182/blood.v122.21.675.675","title":"Ibrutinib In Combination With Rituximab (iR) Is Well Tolerated and Induces a High Rate Of Durable Remissions In Patients With High-Risk Chronic Lymphocytic Leukemia (CLL): New, Updated Results Of a Phase II Trial In 40 Patients","display_name":"Ibrutinib In Combination With Rituximab (iR) Is Well Tolerated and Induces a High Rate Of Durable Remissions In Patients With High-Risk Chronic Lymphocytic Leukemia (CLL): New, Updated Results Of a Phase II Trial In 40 Patients","publication_year":2013,"publication_date":"2013-11-15","ids":{"openalex":"https://openalex.org/W100713916","doi":"https://doi.org/10.1182/blood.v122.21.675.675","mag":"100713916"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v122.21.675.675","doi":"https://doi.org/10.1182/blood.v122.21.675.675","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v122.21.675.675","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058755419","display_name":"Jan A. Burger","orcid":"https://orcid.org/0000-0002-6177-7572","observed_orcids":["https://orcid.org/0000-0002-6177-7572"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jan A. Burger","raw_affiliation_strings":["Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA,","Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA,","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027575595","display_name":"Michael J. Keating","orcid":"https://orcid.org/0000-0002-9121-6450","observed_orcids":["https://orcid.org/0000-0002-9121-6450"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael J. Keating","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA,","Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA,","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089428686","display_name":"William G. Wierda","orcid":"https://orcid.org/0000-0002-7357-270X","observed_orcids":["https://orcid.org/0000-0002-7357-270X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William G. Wierda","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX, USA,","The University of Texas, MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX, USA,","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"The University of Texas, MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056852211","display_name":"Julia Hoellenriegel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Julia Hoellenriegel","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, TX, USA,","The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, TX, USA,","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072373439","display_name":"Ghayathri Jeyakumar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ghayathri Jeyakumar","raw_affiliation_strings":["Leukemia, MD Anderson Cancer Center, Houston, TX, USA,","Leukemia, Md. Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia, MD Anderson Cancer Center, Houston, TX, USA,","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Leukemia, Md. Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028845635","display_name":"Alessandra Ferrajoli","orcid":"https://orcid.org/0000-0001-9547-4193","observed_orcids":["https://orcid.org/0000-0001-9547-4193"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alessandra Ferrajoli","raw_affiliation_strings":["Department of Leukemia, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA,","Department of Leukemia, The University of Texas M. D. Anderson Cancer Center , Houston, TX , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA,","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Department of Leukemia, The University of Texas M. D. Anderson Cancer Center , Houston, TX , USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046097970","display_name":"Stefan H Faderl","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stefan H. Faderl","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA,","Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA,","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068700680","display_name":"Marylou C\u00e1rdenas-Turanzas","orcid":"https://orcid.org/0000-0003-1834-3696","observed_orcids":["https://orcid.org/0000-0003-1834-3696"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Marylou Cardenas-Turanzas","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX, USA,","The University of Texas, MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX, USA,","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"The University of Texas, MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035354255","display_name":"Susan A. Lerner","orcid":"https://orcid.org/0000-0002-5407-4625","observed_orcids":["https://orcid.org/0000-0002-5407-4625"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Susan Lerner","raw_affiliation_strings":["Department of Leukemia, The University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA,","Department of Leukemia, The University of Texas M. D. Anderson Cancer Center , Houston, TX , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA,","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Department of Leukemia, The University of Texas M. D. Anderson Cancer Center , Houston, TX , USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034463709","display_name":"Gracy Zacharian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Gracy Zacharian","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX, USA,","The University of Texas, MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX, USA,","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"The University of Texas, MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057822243","display_name":"Xuelin Huang","orcid":"https://orcid.org/0000-0003-1192-9336","observed_orcids":["https://orcid.org/0000-0003-1192-9336"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Xuelin Huang","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX, USA,","The University of Texas, MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX, USA,","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"The University of Texas, MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090435894","display_name":"Hagop M. Kantarjian","orcid":"https://orcid.org/0000-0002-1908-3307","observed_orcids":["https://orcid.org/0000-0002-1908-3307"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hagop M. Kantarjian","raw_affiliation_strings":["University of Texas, MD Anderson Cancer Center, Houston, TX, USA","University of Texas MD Anderson Cancer Center, Houston, TX, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas, MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"University of Texas MD Anderson Cancer Center, Houston, TX, USA;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5102743501","display_name":"Susan Mary O'Brien","orcid":"https://orcid.org/0000-0003-3386-6540","observed_orcids":["https://orcid.org/0000-0003-3386-6540"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susan O'Brien","raw_affiliation_strings":["Leukemia, MD Anderson Cancer Center, Houston, TX, USA,","Leukemia, Md. Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia, MD Anderson Cancer Center, Houston, TX, USA,","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Leukemia, Md. Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5034463709","https://openalex.org/A5035354255","https://openalex.org/A5056852211","https://openalex.org/A5057822243","https://openalex.org/A5068700680","https://openalex.org/A5072373439"],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":5.9394,"has_fulltext":false,"cited_by_count":42,"citation_normalized_percentile":{"value":0.97197723,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"122","issue":"21","first_page":"675","last_page":"675"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ibrutinib","display_name":"ibrutinib","score":0.9779999852180481},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.9800000190734863},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9430000185966492},{"id":"https://openalex.org/keywords/high-risk-cll","display_name":"high-risk CLL","score":0.8610000014305115},{"id":"https://openalex.org/keywords/bruton-tyrosine-kinase-inhibitors","display_name":"BTK inhibitors","score":0.7009999752044678},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8420000076293945},{"id":"https://openalex.org/keywords/17p-deletion","display_name":"17p deletion","score":0.6959999799728394},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.9980000257492065},{"id":"https://openalex.org/keywords/del-11q","display_name":"del(11q)","score":0.9480000138282776},{"id":"https://openalex.org/keywords/ighv-mutation-status","display_name":"IGHV mutation status","score":0.6230000257492065},{"id":"https://openalex.org/keywords/overall-response-rate","display_name":"overall response rate","score":0.7429999709129333},{"id":"https://openalex.org/keywords/complete-remission","display_name":"complete remission","score":0.6330000162124634},{"id":"https://openalex.org/keywords/disease-free-survival","display_name":"disease-free survival","score":0.6520000100135803},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7960000038146973},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.3889999985694885},{"id":"https://openalex.org/keywords/relapsed-cll","display_name":"relapsed CLL","score":0.5270000100135803}],"concepts":[{"id":"https://openalex.org/C2779878957","wikidata":"https://www.wikidata.org/wiki/Q5984881","display_name":"Ibrutinib","level":4,"score":0.9649832844734192},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8634853959083557},{"id":"https://openalex.org/C2777609679","wikidata":"https://www.wikidata.org/wiki/Q5971015","display_name":"IGHV@","level":4,"score":0.8217206001281738},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6661920547485352},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.6520941257476807},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.6252772212028503},{"id":"https://openalex.org/C90059517","wikidata":"https://www.wikidata.org/wiki/Q423572","display_name":"Bruton's tyrosine kinase","level":4,"score":0.5710344314575195},{"id":"https://openalex.org/C2777525834","wikidata":"https://www.wikidata.org/wiki/Q268713","display_name":"Mantle cell lymphoma","level":3,"score":0.5235664248466492},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5032152533531189},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.47935253381729126},{"id":"https://openalex.org/C2779709957","wikidata":"https://www.wikidata.org/wiki/Q17093208","display_name":"Median follow-up","level":3,"score":0.435257226228714},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.41981077194213867},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3596048355102539},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.35308676958084106},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.32615137100219727},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.23359093070030212},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.18365293741226196},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v122.21.675.675","doi":"https://doi.org/10.1182/blood.v122.21.675.675","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v122.21.675.675","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.5,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1830209188","https://openalex.org/W2990290302","https://openalex.org/W3083764575","https://openalex.org/W2557815702","https://openalex.org/W2955099322","https://openalex.org/W2168006562","https://openalex.org/W2614001962","https://openalex.org/W2512656347","https://openalex.org/W2981016883","https://openalex.org/W2047415399"],"abstract_inverted_index":{"Abstract":[0],"The":[1,202,277],"Bruton":[2],"tyrosine":[3],"kinase":[4],"(BTK)":[5],"inhibitor":[6],"ibrutinib":[7,30,54,58,83,115,480,504,523],"is":[8,453,496],"a":[9,72,156,213,438,454],"promising":[10],"new":[11],"targeted":[12],"therapy":[13,226,505],"for":[14,98,243,263,272,459,549],"patients":[15,112,146,170,182,186,197,223,240,282,297,327],"with":[16,61,71,82,139,155,231,283,360,437,451,473],"mature":[17],"B":[18],"cell":[19,25,353],"malignancies,":[20],"especially":[21],"CLL":[22,138,461,553],"and":[23,50,165,180,256,317,323,348,367,389,410,422,444,488,492,510],"mantle":[24],"lymphoma":[26],"(MCL).":[27],"Single":[28],"agent":[29],"induces":[31,464],"an":[32,264,517,534],"overall":[33,420,511],"response":[34,244],"rate":[35],"(ORR)":[36],"of":[37,75,143,151,158,217,221,229,266,311,315,332,365,370,424,467,501,522,537,551],"71%":[38],"in":[39,55,279,449,476,516,526],"relapsed":[40,137],"CLL,":[41,57],"based":[42,430],"on":[43,114,225,431,533],"the":[44,90,99,144,195,280,295,375,432,482,494,499],"Phase":[45,66],"1/2":[46],"experience.":[47],"To":[48],"accelerate":[49],"improve":[51],"responses":[52],"to":[53,351,479,503],"high-risk":[56,120,460,552],"was":[59,95,206,270,288,357],"combined":[60],"rituximab;":[62],"we":[63],"update":[64],"this":[65],"2":[67,159,292],"single-center":[68],"clinical":[69],"trial":[70,521],"median":[73,149,157,203,214],"follow-up":[74],"14":[76,218],"months.":[77,446],"Methods":[78],"Patients":[79],"were":[80,241,380,471],"treated":[81],"420":[84],"mg":[85],"PO":[86],"daily":[87],"continuously":[88],"throughout":[89],"study":[91,330],"Rituximab":[92],"(375":[93],"mg/m2)":[94],"administered":[96],"weekly":[97],"first":[100],"four":[101],"weeks":[102],"(cycle":[103],"1),":[104],"then":[105],"monthly":[106],"until":[107],"cycle":[108],"6.at":[109],"which":[110,435,463],"point":[111],"continued":[113],"monotherapy.":[116],"Study":[117],"inclusion":[118],"required":[119],"disease":[121,237],"(del17p":[122],"or":[123,127,136,173,233,285,413,539],"TP53":[124,174,234,286],"mutation":[125,175,287],"[treated":[126],"untreated]),":[128],"PFS":[129],"<":[130],"36":[131],"months":[132],"after":[133,427],"frontline":[134],"chemo-immunotherapy,":[135],"del11q.":[140,184],"Results":[141],"Characteristics":[142],"40":[145,222],"enrolled":[147],"included":[148,395],"age":[150],"65":[152],"(range":[153],"35\u201382)":[154],"prior":[160,178],"therapies.":[161],"There":[162,379],"were14":[163],"female":[164],"26":[166],"male":[167],"patients.":[168,554],"20":[169,230,281],"had":[171,183,187,198,345],"del17p":[172,232,284],"(4":[176],"without":[177,236],"therapy),":[179],"13":[181],"32":[185,220],"unmutated":[188],"IGHV,":[189,194],"only":[190],"one":[191,339,343,349],"patient":[192,303,344],"mutated":[193],"remaining":[196],"inconclusive":[199],"IGHV":[200],"results.":[201],"\u03b22":[204],"microglobulin":[205],"4.2":[207],"mg/L":[208],"(2.2":[209],"\u2013":[210],"12.3),":[211],"At":[212],"follow":[215],"up":[216],"months,":[219,429],"continue":[224],"(16":[227,290],"out":[228],"mutation)":[235],"progression.":[238],"39":[239],"evaluable":[242],"assessment":[245],"per":[246],"2008":[247],"IWCLL":[248],"guidelines;":[249],"34":[250],"(87%)":[251],"achieved":[252],"partial":[253],"remission":[254,260],"(PR),":[255],"three":[257],"(8%)":[258],"complete":[259],"(CR),":[261],"accounting":[262],"ORR":[265,278,495],"95%.":[267],"One":[268],"CR":[269],"negative":[271],"MRD":[273],"by":[274],"flow":[275],"cytometry,":[276],"90%":[289],"PR,":[291],"CR).":[293],"Among":[294],"8":[296],"that":[298],"came":[299,328],"off":[300,329],"study,":[301],"3":[302,341,368,443],"died":[304,319],"from":[305,320],"unrelated":[306,321],"infectious":[307,361],"complications":[308,362],"(2":[309],"cases":[310,364,369],"sepsis,":[312],"1":[313,318,401],"case":[314],"pneumonia),":[316],"respiratory":[322,372],"cardiovascular":[324],"failure.":[325],"Two":[326],"because":[331],"possibly":[333,384],"ibrutinib-related":[334],"toxicity":[335],"(one":[336],"subdural":[337,402],"hematoma,":[338],"grade":[340],"mucositis),":[342],"progressive":[346],"disease,":[347],"proceeded":[350],"stem":[352],"transplantation.":[354],"Treatment":[355],"generally":[356],"well":[358,456],"tolerated,":[359],"(6":[363],"pneumonia":[366],"upper":[371],"infections)":[373],"being":[374],"most":[376],"common":[377],"complication.":[378],"two":[381],"Grade":[382,396,400],"3,":[383],"related":[385],"AEs:":[386],"mucositis":[387],"(n=1),":[388,404],"peripheral":[390],"neuropathy":[391],"(n=1).":[392,415],"Milder":[393],"toxicities":[394],"1-2":[397],"bruising":[398],"(n=7),":[399],"hematoma":[403],"fatigue":[405],"(n=2),":[406],"bone":[407],"pain,":[408],"myalgias,":[409],"arthralgia":[411],"(n=5),":[412],"diarrhea":[414],"Questionnaires":[416],"revealed":[417],"significantly":[418],"improved":[419],"health":[421],"quality":[423],"life":[425],"(QOL)":[426],"6":[428,445],"EORTC-QOL-v.3":[433],"questionnaire,":[434],"coincided":[436],"significant":[439,474],"weight":[440],"gain":[441],"at":[442],"Conclusion":[447],"Ibrutinib":[448,547],"combination":[450],"rituximab":[452,502],"safe,":[455],"tolerated":[457],"regimen":[458],"patients,":[462],"high":[465],"rates":[466],"durable":[468],"responses.":[469],"Responses":[470],"associated":[472],"improvements":[475],"QOL.":[477],"Compared":[478],"monotherapy,":[481],"redistribution":[483],"lymphocytosis":[484],"resolves":[485],"more":[486],"rapidly":[487],"completely":[489],"(see":[490],"Figure),":[491],"consequently":[493],"higher.":[497],"Whether":[498],"addition":[500],"translates":[506],"into":[507],"longer":[508],"progression-free":[509],"survival":[512],"will":[513],"be":[514],"addressed":[515],"upcoming":[518],"larger,":[519],"randomized":[520],"versus":[524],"iR":[525],"relapsed/refractory":[527],"CLL.":[528],"Disclosures:":[529],"Burger:":[530],"Pharmacyclics:":[531],"Membership":[532],"entity\u2019s":[535],"Board":[536],"Directors":[538],"advisory":[540],"committees,":[541],"Research":[542,556],"Funding.":[543,557],"Off":[544],"Label":[545],"Use:":[546],"(PCI-32765)":[548],"treatment":[550],"O'Brien:Pharmacyclics:":[555]},"counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":27}],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2025-10-10T00:00:00"}